Cover Image
市場調查報告書

美國的末稍血管疾病管理取向介入性技術市場

U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders

出版商 Medtech Insight 商品編碼 293854
出版日期 內容資訊 英文 273 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的末稍血管疾病管理取向介入性技術市場 U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders
出版日期: 2014年01月20日 內容資訊: 英文 273 Pages
簡介

2012年在美國,進行了380萬件末稍血管疾病(PVD)的診斷、治療的介入性治療,相關產品的銷售額推算上升到16億7,000萬美元。PVD管理的診斷、治療用介入治療數,在預測期間預計以年複合成長率2.0%增加,2013年達到約420萬件。還有,相關產品的銷售額,在預測期間以年複合成長率6.0%增加,2013年達到22億美元。

本報告提供美國的末稍血管疾病診斷產品、治療產品的市場分析及主要企業簡介,為您概述為以下內容。

摘要整理

第1章 末稍血管疾病概要

  • 循環系的組織、生理功能
  • 末稍血管疾病的種類

第2章 介入性末稍血管疾病診斷產品市場

  • 非侵入性末稍血管疾病診斷
  • 介入性末稍血管疾病診斷:市場分析

第3章 介入性末稍血管疾病治療產品市場

  • 非侵入性末稍血管疾病治療
  • 外科的/內視鏡的末稍血管疾病治療
  • 非侵入性末稍血管疾病治療:市場分析

第4章 企業簡介

  • Abbott Laboratories
  • AccessClosure, Inc.
  • AngioDynamics, Inc.
  • Arrow International/Teleflex, Inc.
  • C.R. Bard, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cardiovascular Systems, Inc.
  • Cardiva Medical, Inc.
  • Cook Medical/Cook Group
  • Cordis Corporation/Johnson & Johnson
  • Covidien
  • MEDRAD, Inc./Bayer HealthCare/Bayer Group
  • Merit Medical Systems, Inc.
  • Spectranetics Corporation
  • St. Jude Medical, Inc.
  • Terumo Interventional Systems/Terumo Corporation
  • Volcano Corporation
目錄
Product Code: A248

Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism.

In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.67 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 2.0% during the forecast period covered by this report, reaching nearly 4.2 million in the year 2013. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 6.0% during the forecast period covered by this report, reaching an estimated $2.2 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; drug-eluting balloon systems; cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; vascular puncture closure devices; and vena cava filters, among others.

Table of Contents

Executive Summary

  • i. Interventional Peripheral Vascular Disease Diagnostic Products Market
    • a. Angiography
    • b. Intravascular Ultrasound
  • ii. Interventional Peripheral Vascular Disease Treatment Products Market
    • a. Percutaneous Transluminal Angioplasty
    • b. Catheter-Directed Thrombolysis
    • c. Mechanical Atherectomy
    • d. Endovascular Embolization
    • e. Thrombectomy
    • f. Vena Cava Filter Placement
    • g. Vascular Puncture Hemostasis
    • h. Cryotherapy
  • iii. Methodology
  • Exhibit ES-1: Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2012-2017
  • Exhibit ES-2: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2012-2017
  • Exhibit ES-3: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, by Segment 2012-2017
  • Exhibit ES-4: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017
  • Exhibit ES-5: Intravascular Ultrasound Catheters, Market Forecast, 2012-2017
  • Exhibit ES-6: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017
  • Exhibit ES-7: Catheter-Directed Thrombolysis Systems, Market Forecast, 2012-2017
  • Exhibit ES-8: Mechanical Atherectomy Systems, Market Forecast, 2012-2017
  • Exhibit ES-9: Endovascular Embolization Products, Market Forecast, 2012-2017
  • Exhibit ES-10: Thrombectomy Systems, Market Forecast, 2012-2017
  • Exhibit ES-11: Vena Cava Filter Systems, Market Forecast, 2012-2017
  • Exhibit ES-12: Vascular Puncture Closure Systems, Market Forecast, 2012-2017
  • Exhibit ES-13: Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

1. PERIPHERAL VASCULAR DISEASE OVERVIEW

  • 1.1 Anatomy and Physiology of the Circulatory System
  • 1.2 Types of Peripheral Vascular Disease
    • 1.2.1 Peripheral Artery Disease
      • 1.2.1.1 Etiology
      • 1.2.1.2 Epidemiology
    • 1.2.2 Aneurysm
      • 1.2.2.1 Etiology
      • 1.2.2.2 Epidemiology
    • 1.2.3 Deep Vein Thrombosis and Pulmonary Embolism
      • 1.2.3.1 Etiology
      • 1.2.3.2 Epidemiology
    • 1.2.4 Chronic Venous Insufficiency
      • 1.2.4.1 Etiology
      • 1.2.4.2 Epidemiology
  • Exhibit 1-1: 2013, Peripheral Artery Disease, Facts and Figures
  • Exhibit 1-2: 2013, Aortic Aneurysm, Facts and Figures
  • Exhibit 1-3: 2013, Deep Vein Thrombosis, Facts and Figures
  • Exhibit 1-4: Classification of Chronic Venous Insufficiency
  • Exhibit 1-5: 2013, Chronic Venous Insufficiency, Facts and Figures

2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET

  • 2.1 Noninvasive Peripheral Vascular Disease Diagnostics
    • 2.1.1 Ankle/Brachial Index
    • 2.1.2 Exercise Tolerance Testing
    • 2.1.3 Imaging Methods
      • 2.1.3.1 Computed Tomography
      • 2.1.3.2 Magnetic Resonance Imaging
      • 2.1.3.3 Diagnostic Ultrasound Imaging
    • 2.1.4 Photoplethysmography and Air Plethysmography
  • 2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis
    • 2.2.1 Angiography
      • 2.2.1.1 Types
        • 2.2.1.1.1 Peripheral Arterial Angiography
        • 2.2.1.1.2 Peripheral Venous Angiography
        • 2.2.1.1.3 Ascending and Descending Venography
        • 2.2.1.1.4 Venographic Applications for Deep Vein Thrombosis in Lower and Upper Extremities
      • 2.2.1.2 Procedures/Technologies
      • 2.2.1.3 Products
      • 2.2.1.4 Market Forecast
      • 2.2.1.5 Competitors
    • 2.2.2 Intravascular Ultrasound
      • 2.2.2.1 Procedures/Technologies
      • 2.2.2.2 Products
      • 2.2.2.3 Market Forecast
      • 2.2.2.4 Competitors
  • Exhibit 2-1: Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2012-2017
  • Exhibit 2-2: Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2012-2017
  • Exhibit 2-3: Peripheral Angiography, Procedure Volumes Forecast, 2012-2017
  • Exhibit 2-4: 2013, Selected Angiography Catheters
  • Exhibit 2-5: 2013, Selected Diagnostic Guidewires
  • Exhibit 2-6: 2013, Selected Introducers/Sheaths
  • Exhibit 2-7: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017
  • Exhibit 2-8: 2012, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier
  • Exhibit 2-9: Intravascular Ultrasound, Procedure Volumes Forecast, 2012-2017
  • Exhibit 2-10: 2013, Selected Intravascular Ultrasound Catheters and Systems
  • Exhibit 2-11: Intravascular Ultrasound Products, Market Forecast, 2012-2017
  • Exhibit 2-12: 2012, Intravascular Ultrasound Products Market, Share by Supplier

3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET

  • 3.1 Noninvasive Peripheral Vascular Disease Treatments
  • 3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments
    • 3.2.1 Peripheral Artery Surgery
      • 3.2.1.1 Aortofemoral Bypass Graft Surgery
      • 3.2.1.2 Distal Tibial-Peroneal Vascular Reconstruction
      • 3.2.1.3 Femoropopliteal Bypass Graft Surgery
    • 3.2.2 Thromboendarterectomy
    • 3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments
      • 3.2.3.1 Deep Vein Reconstruction
      • 3.2.3.2 Open Subfascial Perforator Surgery
      • 3.2.3.3 Sclerotherapy
      • 3.2.3.4 Skin Grafting
      • 3.2.3.5 Subfascial Endoscopic Perforator Surgery
      • 3.2.3.6 Superficial Vein Stripping
  • 3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis
    • 3.3.1 Percutaneous Transluminal Angioplasty
      • 3.3.1.1 Procedures/Technologies
      • 3.3.1.2 Products
        • 3.3.1.2.1 Balloon Catheters
        • 3.3.1.2.2 Guiding Catheters
        • 3.3.1.2.3 Guidewires
        • 3.3.1.2.4 Introducers/Sheaths
        • 3.3.1.2.5 Accessories
      • 3.3.1.2 Market Forecast
      • 3.3.1.3 Competitors
    • 3.3.2 Catheter-Directed Thrombolysis
      • 3.3.2.1 Procedures/Technologies
      • 3.3.2.2 Products
      • 3.3.2.3 Market Forecast
      • 3.3.2.4 Competitors
    • 3.3.3 Mechanical Atherectomy
      • 3.3.3.1 Procedures/Technologies
      • 3.3.3.2 Products
      • 3.3.3.3 Market Forecast
      • 3.3.3.4 Competitors
    • 3.3.4 Endovascular Embolization
      • 3.3.4.1 Procedures/Technologies
      • 3.3.4.2 Products
      • 3.3.4.3 Market Forecast
      • 3.3.4.4 Competitors
    • 3.3.5 Thrombectomy
      • 3.3.5.1 Procedures/Technologies
      • 3.3.5.2 Products
      • 3.3.5.3 Market Forecast
      • 3.3.5.4 Competitors
    • 3.3.6 Vena Cava Filter Placement
      • 3.3.6.1 Procedures/Technologies
      • 3.3.6.2 Products
      • 3.3.6.3 Market Forecast
      • 3.3.6.4 Competitors
    • 3.3.7 Vascular Puncture Hemostasis Tools and Techniques
      • 3.3.7.1 Procedures/Technologies
      • 3.3.7.2 Products
      • 3.3.7.3 Market Forecast
      • 3.3.7.4 Competitors
    • 3.3.8 Cryotherapy
      • 3.3.8.1 Procedures/Technologies
      • 3.3.8.2 Products
      • 3.3.8.3 Market Forecast
  • Exhibit 3-1: Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-2: Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2012-2017
  • Exhibit 3-3: Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-4: 2013, Selected Percutaneous Transluminal Angioplasty Balloon Catheters
  • Exhibit 3-5: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017
  • Exhibit 3-6: 2012, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier
  • Exhibit 3-7: Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-8: 2013, Selected Catheter-Directed Thrombolysis Systems
  • Exhibit 3-9: Catheter-Directed Thrombolysis Systems, Market Forecast, 2012-2017
  • Exhibit 3-10: 2012, Catheter-Directed Thrombolysis Systems Market, Share by Supplier
  • Exhibit 3-11: Mechanical Atherectomy, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-12: 2013, Selected Mechanical Atherectomy Systems
  • Exhibit 3-13: Mechanical Atherectomy Systems, Market Forecast, 2012-2017
  • Exhibit 3-14: 2012, Mechanical Atherectomy Systems, Share by Supplier
  • Exhibit 3-15: Endovascular Embolization, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-16: 2013, Selected Endovascular Embolization Products
  • Exhibit 3-17: Endovascular Embolization Products, Market Forecast, 2012-2017
  • Exhibit 3-18: 2012, Endovascular Embolization Products Market, Share by Supplier
  • Exhibit 3-19: Thrombectomy, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-20: 2013, Selected Thrombectomy Systems
  • Exhibit 3-21: Thrombectomy, Market Forecast, 2012-2017
  • Exhibit 3-22: 2012, Thrombectomy Systems Market, Share by Supplier
  • Exhibit 3-23: Vena Cava Filter Placement, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-24: 2013, Selected Vena Cava Filter Systems
  • Exhibit 3-25: Vena Cava Filter Systems, Market Forecast, 2012-2017
  • Exhibit 3-26: 2012, Vena Cava Filter Systems Market, Share by Supplier
  • Exhibit 3-27: Vascular Puncture Closure Systems, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-28: 2013, Selected Vascular Puncture Closure Systems
  • Exhibit 3-29: Vascular Puncture Closure Systems, Market Forecast, 2012-2017
  • Exhibit 3-30: 2012, Vascular Puncture Closure Systems Market, Share by Supplier
  • Exhibit 3-31: Endovascular Cryotherapy, Procedure Volumes Forecast, 2012-2017
  • Exhibit 3-32: Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

4. COMPANY PROFILES

  • 4.1 Abbott Laboratories
  • 4.2 AccessClosure, Inc.
  • 4.3 AngioDynamics, Inc.
  • 4.4 Arrow International/Teleflex, Inc.
  • 4.5 C.R. Bard, Inc.
  • 4.6 Boston Scientific Corporation
  • 4.7 B. Braun Melsungen AG
  • 4.8 Cardiovascular Systems, Inc.
  • 4.9 Cardiva Medical, Inc.
  • 4.10 Cook Medical/Cook Group
  • 4.11 Cordis Corporation/Johnson & Johnson
  • 4.12 Covidien
  • 4.13 MEDRAD, Inc./Bayer HealthCare/Bayer Group
  • 4.14 Merit Medical Systems, Inc.
  • 4.15 Spectranetics Corporation
  • 4.16 St. Jude Medical, Inc.
  • 4.17 Terumo Interventional Systems/Terumo Corporation
  • 4.18 Volcano Corporation

APPENDIX: COMPANY LISTING

Back to Top